Cellomatics scoops regional award for the second successive year

For the second consecutive year, Cellomatics Biosciences has been selected as a regional winner in the annual Barclays Entrepreneur Awards and shortlisted as a finalist in the International Expansion Category.

No stranger to awards, Cellomatics picked up the Queen’s Award for Enterprise for International Trade earlier this year.

The company’s laboratory services export business has increased over 15-fold, with export sales now representing approximately 50 percent of total revenue. Significant growth has come from clients based in Europe, Asia and the USA.

The Awards

Barclays Entrepreneur Awards celebrates entrepreneurs for their exceptional innovation, and for creating social change and growth that’s moving the UK forward.  Now in their seventh year, the awards highlights and recognises businesses from the UK that are changing their industries, the economy and society in unique, original, and positive ways.

There are ten individual awards to be won, from Start-Up and Scale-Up Entrepreneur of the Year to Icon of the Year. 

Barclays People’s Choice Award – Make Your Vote Count!

You can also have your say as all shortlisted winners are being entered into The People’s Choice Award.  If you’d like to vote for Cellomatics, The People’s Choice Award are open for nominations until midnight on the 30th September. The business receiving the highest number of valid votes by the closing date will be announced the winner at the Awards Ceremony which will be held on the 3rd November 2022 at The Science Museum in London. You can vote here

Click here for more information on the Barclays Awards.

Request a consultation with Cellomatics Biosciences today

Our experienced team of in vitro laboratory scientists will work with you to understand your project and provide a bespoke project plan with a professional, flexible service and a fast turnaround time.

To request a consultation where we can discuss your exact requirements, please contact Cellomatics Biosciences.